NCT05284032 2024-07-31A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)University of VirginiaPhase EARLY_PHASE1 Terminated3 enrolled